S1 Antioxidant and antimicrobial assessment of synthesized and spectrally characterized new nitrophenothiazines and their sulfone analogues Naveen Gautam1, Ankita Garg*2, Ajay Kumar Bishnoi2, Shikha Agarwal3, Dinesh Chand Gautam2 1 2 Government P.G. College, Kotputli, Jaipur 303108 Department of Chemistry, University of Rajasthan, Jaipur 302004 3 MLS University, Udaipur, 313001, India Email: garg_ankita01@yahoo.com Supplemental Materials Biological Activity of the synthesized compounds Antioxidant Activity The synthesized compounds were screened for antioxidant activity by 1,1-diphenyl-2picrylhydrazyl (DPPH) radical scavenging assay and 2,2-azinobis(3-ethylbenzothiazoline-6sulfonic acid) (ABTS●+) radical cation decolorization assay. The results are tabulated in Tables S 1 and S 2. DPPH Radical Scavenging Assay Radical scavenging activity of all synthesized compounds was determined spectrophotometrically against stable 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical by Cuendet et al39. ABTS Radical Cation Decolorization Assay The (ABTS●+) assay was carried out using the improved assay of Re et al.40, which is based on the oxidation of ABTS with potassium persulfate leading to (ABTS●+). S2 Results and Discussion All the synthesized compounds were screened for their antioxidant activity by 1,1diphenyl-2-picryl hydrazyl (DPPH) radial scavenging assay and 2,2´-azinobis(3- ethylbenzothiazoline-6-sulfonic acid) (ABTS.+) radical cation decolorization assay. The present study41-43 demonstrated that the synthesized compounds showed mixed radical scavenging activity in both DPPH and ABTS assays. (a) Those compounds showed strong radical scavenging activity in DPPH assay that have DPPH% inhibition > 50. (b) Those compounds showed moderate radical scavenging activity in DPPH assay that have DPPH% inhibition > 30. (c) Those compounds showed mild radical scavenging activity in DPPH assay that have DPPH% inhibition < 30. (d) Those compounds were found to be more active in ABTS assay which showed activity near to standard compound. Antimicrobial Activity Antibacterial Activity : In this method, paper disc impregnated with compounds dissolved in solvent DMF at concentrations 25, 50 and 100 μg mL-1. Then the disc impregnated with the solution was placed on the surface of the media inoculated with the bacterial strain. The plates were incubated at 35°C for 24 h for bacterial cultures. After incubation, the zones inhibition around the disc were observed. Each testing is done in triplicate. Ciprofloxacin/ Ampicillin sulfate at conc. 50 μg mL-1 was used as standard drug for antibacterial activity. results were interpreted in terms of diameter (mm) of zone of inhibition. The % Activity Index for the complex was calculated by the formula as under: S3 % Activity Index= Zone of inhibition by test compound (diameter) 100 Zone of inhibition by standard (diameter) Antifungal activity Antifungal activity of synthesized compounds was tested on fungal strains: A. niger, C. albicans, Aspergillus solani MTCC 2101, Fusarium culmorum MTCC 349 using disc diffusion method. In the disc-diffusion method, disc impregnated with compounds dissolved in solvent DMF at concentrations 25, 50 and 100 μg mL-1 were spread over microorganism culture in nutrient agar medium. The plates were incubated at 25°C for 48 h for fungal strains. After incubation the growth inhibiting zones around the disc was observed. Growth inhibiting zone indicates that the compounds inhibit growth of microorganism. Each experiment is done in triplicate. Griseofulvin/ fluconazole at concentration 50 μgmL-1 was used as standard drug for antifungal activity. Results were interpreted in terms of diameter (mm) of zone of inhibition. The percentage inhibition was calculated by the following equation. % Inhibition = (C–T) 100/C Where, C and T are the diameters of the fungal colony in the control and the test plates, respectively. Minimum Inhibitory Concentrations: Minimum inhibitory concentrations (MICs) are defined as the lowest concentration of antimicrobials that inhibit the visible growth of a microorganism after overnight incubation at 37°C. Determination of the MIC is a semiquantitative test, which gives an approximate idea of the least concentration of an antimicrobial (test) solution needed to parent microbial growth. The MIC was determined by the liquid dilution method. Gram positive bacteria (Staphylococcus aureus, Bacillus subtilis, Micromonospora sp. MTCC 3296) and gram negative bacteria (Escherichia coli, Pseudomonas aeruginosa, Zymomonas mobilis MTCC 88) were used as quality control strains. For the antifungal activities of the compounds Candida S4 albicans, Aspergillus niger, Aspergillus solani MTCC 2101, Fusarium culmorum MTCC 349 were tested. Ciprofloxacin/ Ampicillin sulfate and Griseofulvin/ fluconazole were used as standard antibacterial and antifungal agents. The stock solutions of test compounds with 1 to 20 μg/mL concentrations were prepared with aqueous methanol. Inoculums of the overnight culture were prepared. In a series of tubes, 1 mL each of stock solutions of test compound with different concentrations was taken and 0.4 mL of the inoculums was added to each tube. Further 4.0 mL of sterile water was added to each of the test tubes. These test tubes were incubated for 22-24 h and observed for the presence of turbidity. The absorbance of the suspension of the inoculums was observed with spectrophotometer at 555 nm. The end result of the test was the minimum concentration of antimicrobial (test) solutions, which gave clear solution, i.e. no visual growth. The activity indices of tested compounds against certain bacteria and fungi were calculated and the results are tabulated in Tables S 3 - S 6. S5 Table S 1 : Antioxidant activity of synthesized substituted nitrophenothiazines 3c-e Compounds DPPH% Inhibitory (1mg/mL) ABTS. + activity at different time intervals 0 min. 3c 3d 3e Ascorbic acid 39.77±0.50 52.03±1.2 27.12±1.5 - 0.690 0.697 0.689 0.694 1 min. 0.503 0.256 0.679 0.040 2 min. 0.155 0.142 0.392 0.003 4 min. 6 min. 0.141 0.118 0.219 0.003 0.112 0.103 0.150 0.003 4 min. 6 min. Ascorbic acid is used as reference compound whose DPPH % inhibition of 1 mg/ml is 92.96% Table S 2 : Antioxidant activity of synthesized substituted nitrophenothiazine sufones 4c-e Compounds DPPH% Inhibitory (1mg/mL) ABTS. + activity at different time intervals 0 min. 4c 4d 4e Ascorbic acid 48.84±0.01 31.15±0.10 48.59±0.09 - 0.691 0.717 0.692 0.694 1 min. 0.444 0.569 0.242 0.040 Ascorbic acid is used as reference compound whose DPPH % inhibition of 1 mg/ml is 92.96% 2 min. 0.099 0.396 0.110 0.003 0.082 0.333 0.100 0.003 0.070 0.233 0.095 0.003 S6 Table S 3: Antimicrobial activity of synthesized substituted nitrophenothiazines 3a-b Micromonospora sp. MTCC 3296 Compounds IZ AI (cm) Zymomonas mobilis MTCC 88 MIC IZ g/mL) (cm) AI Aspergillus solani MTCC 2101 MIC IZ g/mL) (cm) AI Fusarium culmorum MTCC 349 MIC IZ g/mL) (cm) AI MIC g/mL) 3ª 2.4 0.857 30.0 2.2 1.047 21.0 2.0 0.666 21.5 2.3 0.851 22.0 3b 1.4 0.5 34.5 1.8 0.857 24.0 2.1 0.7 21.0 1.4 0.518 27.5 Ampicillin sulfate 2.8 -- 28.0 2.1 -- 22.0 -- -- -- -- -- -- -- -- -- -- -- 3.0 -- 18.0 2.7 -- 20.0 Fluconazole Ampicillin sulfate and Flucanozol were used as standard antibacterial and antifungal drugs respectively. IZ : Inhibition Zone (cm) AI : Activation Index MIC : Minimum Inhibition Concentration g/mL) S7 Table S 4: Antimicrobial activity of synthesized substituted nitrophenothiazine sulfones 4a-b Compounds Micromonospora sp. MTCC 3296 IZ AI (cm) Zymomonas mobilis MTCC 88 MIC IZ g/mL) (cm) AI Aspergillus solani MTCC 2101 MIC IZ g/mL) (cm) AI Fusarium culmorum MTCC 349 MIC IZ g/mL) (cm) AI MIC g/mL) 4ª 2.7 0.964 28.5 2.0 0.952 23.0 2.2 0.733 20.5 2.1 0.777 23.0 4b 2.6 0.928 29.0 2.2 1.047 21.0 2.1 0.7 21.0 1.5 0.555 27.0 Ampicillin sulfate 2.8 -- 28.0 2.1 -- 22.0 -- -- -- -- -- -- Fluconazole -- -- -- -- -- -- 3.0 -- 18.0 2.7 -- 20.0 Ampicillin sulfate and Flucanozol were used as standard antibacterial and antifungal drugs respectively. IZ : Inhibition Zone (cm) AI : Activation Index MIC : Minimum Inhibition Concentration g/mL) S8 Table S 5 Antimicrobial activity of synthesized substituted nitrophenothiazines 3c-e. Compounds E. coli B. subtilis P. aeruginosa S. aureus C. albicans A. niger MIC (g/mL) of bacterial strain %AI (100 g/mL ) MIC (g/mL) of bacterial strain %AI (100 g/mL ) MIC (g/mL) of bacterial strain %AI (100 g/mL ) MIC (g/mL) of bacterial strain %AI (100 g/mL ) MIC (g/mL) of bacterial strain %I (100 g/mL ) MIC (g/mL) of bacterial strain %I (100 g/mL ) 3c 9.66±0.20 67 9.09±0.11 59 8.14±0.29 64 9.93±0.13 63 9.99±0.19 68 8.88±0.23 70 3d 8.20±0.17 64 9.01±0.21 59 8.72±0.16 67 8.07±0.11 69 10.71±0.39 39 11.48±0.25 45 3e 11.68±0.11 73 12.32±0.12 60 12.11±0.26 60 11.39±0.20 62 11.82±0.17 70 13.31±0.17 72 Ciprofloxacin 04.10±0.10 100 04.90±0.13 100 03.85±0.15 100 04.90±0.11 100 - - - - Griseofulvin - - - - - - - - 03.10±0.80 100 04.80±0.10 100 MIC, Minimum Inhibitory Concentration; AI, Activity Index; I, Inhibition S9 Table S 6 Antimicrobial activity of synthesized substituted nitrophenothiazine sulfones 4c-e. Compounds E. coli B. subtilis P. aeruginosa MIC (g/mL) of bacterial strain %AI (100 g/mL ) MIC (g/mL) of bacterial strain %AI g/mL 4c 8.43±0.21 67 9.11±0.16 4d 9.67±0.19 74 4e 8.19±0.14 Ciprofloxacin Griseofulvin S. aureus C. albicans A. niger MIC (g/mL) of bacterial strain %AI (100 g/mL ) MIC (g/mL) of bacterial strain %AI (100 g/mL ) MIC (g/mL) of bacterial strain %I (100 g/mL ) MIC (g/mL) of bacterial strain %I (100 g/mL ) 50 10.22±0.16 64 9.23±0.14 63 10.68±0.48 68 11.34±0.17 70 10.13±0.17 63 9.44±0.22 67 10.44±0.21 69 10.11±0.18 39 9.86±0.14 45 75 8.71±0.20 58 8.00±0.18 60 8.64±0.18 62 9.62±0.32 70 8.24±0.22 72 04.10±0.10 100 04.90±0.13 100 03.85±0.15 100 04.90±0.11 100 - - - - - - - - - - - - 03.10±0.80 100 04.80±0.10 100 (100 ) MIC, Minimum Inhibitory Concentration; AI, Activity Index; I, Inhibition S 10 Figure S 1: 1H NMR of 3a